[HTML][HTML] Artificial intelligence for multimodal data integration in oncology

J Lipkova, RJ Chen, B Chen, MY Lu, M Barbieri… - Cancer cell, 2022 - cell.com
In oncology, the patient state is characterized by a whole spectrum of modalities, ranging
from radiology, histology, and genomics to electronic health records. Current artificial …

Designing deep learning studies in cancer diagnostics

A Kleppe, OJ Skrede, S De Raedt, K Liestøl… - Nature Reviews …, 2021 - nature.com
The number of publications on deep learning for cancer diagnostics is rapidly increasing,
and systems are frequently claimed to perform comparable with or better than clinicians …

[HTML][HTML] Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease

S Zhao, H Chi, Q Yang, S Chen, C Wu, G Lai… - Frontiers in …, 2023 - frontiersin.org
Background Glioblastoma multiforme (GBM) is the most common cancer of the central
nervous system, while Parkinson's disease (PD) is a degenerative neurological condition …

Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics

YS Choi, S Bae, JH Chang, SG Kang, SH Kim… - Neuro …, 2021 - academic.oup.com
Background Glioma prognosis depends on isocitrate dehydrogenase (IDH) mutation status.
We aimed to predict the IDH status of gliomas from preoperative MR images using a fully …

A fully automated multimodal MRI-based multi-task learning for glioma segmentation and IDH genotyping

J Cheng, J Liu, H Kuang, J Wang - IEEE Transactions on …, 2022 - ieeexplore.ieee.org
The accurate prediction of isocitrate dehydrogenase (IDH) mutation and glioma
segmentation are important tasks for computer-aided diagnosis using preoperative …

Multiclass magnetic resonance imaging brain tumor classification using artificial intelligence paradigm

GS Tandel, A Balestrieri, T Jujaray, NN Khanna… - Computers in Biology …, 2020 - Elsevier
Motivation Brain or central nervous system cancer is the tenth leading cause of death in men
and women. Even though brain tumour is not considered as the primary cause of mortality …

[HTML][HTML] Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging

AAK Abdel Razek, A Alksas, M Shehata… - Insights into …, 2021 - Springer
This article is a comprehensive review of the basic background, technique, and clinical
applications of artificial intelligence (AI) and radiomics in the field of neuro-oncology. A …

Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma

J Luo, M Pan, K Mo, Y Mao, D Zou - Seminars in Cancer Biology, 2023 - Elsevier
Glioma represents a dominant primary intracranial malignancy in the central nervous
system. Artificial intelligence that mainly includes machine learning, and deep learning …

Radiogenomics: a key component of precision cancer medicine

Z Liu, T Duan, Y Zhang, S Weng, H Xu, Y Ren… - British Journal of …, 2023 - nature.com
Radiogenomics, focusing on the relationship between genomics and imaging phenotypes,
has been widely applied to address tumour heterogeneity and predict immune …

[HTML][HTML] A bioinformatics-based analysis of an anoikis-related gene signature predicts the prognosis of patients with low-grade gliomas

S Zhao, H Chi, W Ji, Q He, G Lai, G Peng, X Zhao… - Brain Sciences, 2022 - mdpi.com
Low-grade glioma (LGG) is a highly aggressive disease in the skull. On the other hand,
anoikis, a specific form of cell death induced by the loss of cell contact with the extracellular …